Literature DB >> 22574661

Deposition, diffusion and transport mechanism of dry powder microparticulate salbutamol, at the respiratory epithelia.

Mehra Haghi1, Daniela Traini, Mary Bebawy, Paul M Young.   

Abstract

The deposition, dissolution and transport of salbutamol base (SB) and salbutamol sulfate (SS) inhalation powders were investigated using the Calu-3 air interface cell culture model and Franz diffusion cell. Drug uptake by cells was studied with respect to deposited dose, drug solubility and hydrophobicity. Furthermore, the role of active transport via organic cationic transporters (OCTs) was studied. SB and SS were processed to have similar diameters (3.09 ± 0.06 μm and 3.07 ± 0.03 μm, respectively) and were crystalline in nature. Analysis of drug wetting, dissolution and diffusion using a conventional in vitro Franz cell (incorporating a cell culture support Transwell polyester membrane) showed diffusion of SB to be slower than that of SS (98.57 ± 4.23 μg after 4 h for SB compared to 98.57 ± 4.01 μg after 15 min for SS). Such observations suggest dissolution to be the rate-limiting step. In comparison, the percentage transfer rate using the air interface Calu-3 cell model suggested SB transport to be significantly faster than SS transport (92.02 ± 4.47 μg of SB compared to 63.76 ± 8.84 μg of SS transported over 4 h), indicating that passive diffusion through the cell plays a role in transport. Furthermore, analysis of SB and SS transport, over a range of deposited doses, suggested the transport rate in the Franz diffusion cell to be limited by wetting of the particle and dissolution into the medium. However, for the cell monolayer, the cell membrane properties regulate the diffusion and transport rate. Analysis of the drug transport in the presence of triethylamine (TEA), a known inhibitor of OCTs, resulted in a significant decrease in drug transport, suggesting an active transport mechanism. The presence of OCTs in this cell line was further validated by Western blot analysis. Finally, the transport of SS from a commercial product (Ventolin Rotacaps) was studied and showed good agreement with the model SS system studied here.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22574661     DOI: 10.1021/mp200620m

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  12 in total

1.  Drug Permeation Characterization of Inhaled Dry Powder Formulations in Air-Liquid Interfaced Cell Layer Using an Improved, Simple Apparatus for Dispersion.

Authors:  Ayumu Asai; Tomoyuki Okuda; Erina Sonoda; Tomoyo Yamauchi; Saki Kato; Hirokazu Okamoto
Journal:  Pharm Res       Date:  2015-10-21       Impact factor: 4.200

2.  Dissolution testing of powders for inhalation: influence of particle deposition and modeling of dissolution profiles.

Authors:  Sabine May; Birte Jensen; Claudius Weiler; Markus Wolkenhauer; Marc Schneider; Claus-Michael Lehr
Journal:  Pharm Res       Date:  2014-05-23       Impact factor: 4.200

3.  Evaluation of co-delivery of colistin and ciprofloxacin in liposomes using an in vitro human lung epithelial cell model.

Authors:  Guihong Chai; Heejun Park; Shihui Yu; Fanfan Zhou; Jian Li; Qingguo Xu; Qi Tony Zhou
Journal:  Int J Pharm       Date:  2019-08-12       Impact factor: 5.875

4.  Inhalable Clarithromycin Microparticles for Treatment of Respiratory Infections.

Authors:  Frantiescoli Dimer; Cristiane de Souza Carvalho-Wodarz; Jörg Haupenthal; Rolf Hartmann; Claus-Michael Lehr
Journal:  Pharm Res       Date:  2015-06-26       Impact factor: 4.200

5.  Combined inhaled salbutamol and mannitol therapy for mucus hyper-secretion in pulmonary diseases.

Authors:  Hui Xin Ong; Daniela Traini; Giulia Ballerin; Lucy Morgan; Lachlan Buddle; Santo Scalia; Paul M Young
Journal:  AAPS J       Date:  2014-01-16       Impact factor: 4.009

6.  Formulation and evaluation of carrier-free dry powder inhaler containing sildenafil.

Authors:  Thi-Tram Nguyen; Eun-Jin Yi; Kyu-Mok Hwang; Cheol-Hee Cho; Chun-Woong Park; Ju-Young Kim; Yun-Seok Rhee; Eun-Seok Park
Journal:  Drug Deliv Transl Res       Date:  2019-02       Impact factor: 4.617

7.  In vitro cell integrated impactor deposition methodology for the study of aerodynamically relevant size fractions from commercial pressurised metered dose inhalers.

Authors:  Mehra Haghi; Daniela Traini; Paul Young
Journal:  Pharm Res       Date:  2014-02-19       Impact factor: 4.200

8.  Ciprofloxacin is actively transported across bronchial lung epithelial cells using a Calu-3 air interface cell model.

Authors:  Hui Xin Ong; Daniela Traini; Mary Bebawy; Paul M Young
Journal:  Antimicrob Agents Chemother       Date:  2013-03-18       Impact factor: 5.191

9.  Formulation of Biologically-Inspired Silk-Based Drug Carriers for Pulmonary Delivery Targeted for Lung Cancer.

Authors:  Sally Yunsun Kim; Deboki Naskar; Subhas C Kundu; David P Bishop; Philip A Doble; Alan V Boddy; Hak-Kim Chan; Ivan B Wall; Wojciech Chrzanowski
Journal:  Sci Rep       Date:  2015-08-03       Impact factor: 4.379

10.  Iron-Based Metal-Organic Frameworks as a Theranostic Carrier for Local Tuberculosis Therapy.

Authors:  Gabriela Wyszogrodzka; Przemysław Dorożyński; Barbara Gil; Wieslaw J Roth; Maciej Strzempek; Bartosz Marszałek; Władysław P Węglarz; Elżbieta Menaszek; Weronika Strzempek; Piotr Kulinowski
Journal:  Pharm Res       Date:  2018-05-18       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.